Larger putamen size in antipsychotic-naïve individuals with schizotypal personality disorder

Schizophrenia Research

Volumn 143, Issue 1, 2013, Pages 158-164

  Chemerinski, Eran ^a,b   Byne, William ^a,b   Kolaitis, Jeanine C ^a,b   Glanton, Cathryn F ^a   Canfield, Emily L ^a   Newmark, Randall E ^a   Haznedar, M Mehmet ^a,b   Novakovic, Vladan ^a   Chu, King Wai ^b   Siever, Larry J ^a,b   Hazlett, Erin A ^a,b  

^a MOUNT SINAI SCHOOL OF MEDICINE   (United States)

^b VETERANS AFFAIRS MEDICAL CENTER   (United States)

Author keywords

Caudate; MRI; Putamen; Schizophrenia; Schizotypal personality disorder; Striatal size; Striatum

Indexed keywords

ADULT; ARTICLE; BRAIN SIZE; BRAIN SLICE; CAUDATE NUCLEUS; CONTROLLED STUDY; DISEASE SEVERITY; FEMALE; HEMISPHERE; HUMAN; IMAGE ANALYSIS; MAJOR CLINICAL STUDY; MALE; NUCLEAR MAGNETIC RESONANCE IMAGING; PARANOIA; PRIORITY JOURNAL; PUTAMEN; SCHIZOTYPAL PERSONALITY DISORDER; SYMPTOM;

ADOLESCENT; ADULT; AGED; CORPUS STRIATUM; FEMALE; FUNCTIONAL LATERALITY; HUMANS; IMAGE PROCESSING, COMPUTER-ASSISTED; MAGNETIC RESONANCE IMAGING; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; PUTAMEN; SCHIZOTYPAL PERSONALITY DISORDER; SEVERITY OF ILLNESS INDEX; YOUNG ADULT;

EID: 84871929462     PISSN: 09209964     EISSN: 15732509     Source Type: Journal    
DOI: 10.1016/j.schres.2012.11.003     Document Type: Article

References (58)

1. Abi-Dargham A., Mawlawi O., Lombardo I., Gil R., Martinez D., Huang Y., Hwang D.R., Keilp J., Kochan L., Van Heertum R., Gorman J.M., Laruelle M. Prefrontal dopamine D1 receptors and working memory in schizophrenia. J. Neurosci. 2002, 22(9):3708-3719.
2. Alexander G.E., DeLong M.R., Strick P.L. Parallel organization of functionally segregated circuits linking basal ganglia and cortex. Annu. Rev. Neurosci. 1986, 9:357-381.
3. Benes F.M., Paskevich P.A., Davidson J., Domesick V.B. The effects of haloperidol on synaptic patterns in the rat striatum. Brain Res. 1985, 329(1-2):265-273.
4. Bergman A.J., Harvey P.D., Mitropoulou V., Aronson A., Marder D., Silverman J., Trestman R., Siever L.J. The factor structure of schizotypal symptoms in a clinical population. Schizophr. Bull. 1996, 22(3):501-509.
5. Bernacer J., Prensa L., Gimenez-Amaya J.M. Distribution of GABAergic interneurons and dopaminergic cells in the functional territories of the human striatum. PLoS One 2012, 7(1):e30504.
6. Breier A., Buchanan R.W., Elkashef A., Munson R.C., Kirkpatrick B., Gellad F. Brain morphology and schizophrenia. A magnetic resonance imaging study of limbic, prefrontal cortex, and caudate structures. Arch. Gen. Psychiatry 1992, 49(12):921-926.
7. Brickman A.M., Buchsbaum M.D., Shihabuddin L., Hazlett E.A., Borod J.C., Mohs R.C. Striatal size, glucose metabolic rate, and verbal learning in normal aging. Brain Res. Cogn. Brain Res. 2003, 17(1):106-116.
8. Buchsbaum M.S., Potkin S.G., Siegel B.V., Lohr J., Katz M., Gottschalk L.A., Gulasekaram B., Marshall J.F., Lottenberg S., Teng C.Y., et al. Striatal metabolic rate and clinical response to neuroleptics in schizophrenia. Arch. Gen. Psychiatry 1992, 49(12):966-974.
9. Buchsbaum M.S., Nenadic I., Hazlett E.A., Spiegel-Cohen J., Fleischman M.B., Akhavan A., Silverman J.M., Siever L.J. Differential metabolic rates in prefrontal and temporal Brodmann areas in schizophrenia and schizotypal personality disorder. Schizophr. Res. 2002, 54(1-2):141-150.
10. Buchsbaum M.S., Shihabuddin L., Brickman A.M., Miozzo R., Prikryl R., Shaw R., Davis K. Caudate and putamen volumes in good and poor outcome patients with schizophrenia. Schizophr. Res. 2003, 64(1):53-62.
11. Chakos M., Lieberman J., Bilder R. Increase in caudate nuclei volume of first episode schizophrenia patients taking antipsychotic drugs. Am. J. Psychiatry 1994, 151:1430-1436.
12. Chakos M., Shirakawa O., Lieberman J., Lee H., Bilder R., Tamminga C. Striatal enlargement in rats chronically treated with neuroleptic. Biol. Psychiatry 1998, 44:675-684.
13. Corson P.W., Nopoulos P., Andreasen N.C., Heckel D., Arndt S. Caudate size in first-episode neuroleptic-naive schizophrenic patients measured using an artificial neural network. Biol. Psychiatry 1999, 46(5):712-720.
14. Crow T.J., Ball J., Bloom S.R., Brown R., Bruton C.J., Colter N., Frith C.D., Johnstone E.C., Owens D.G., Roberts G.W. Schizophrenia as an anomaly of development of cerebral asymmetry. A postmortem study and a proposal concerning the genetic basis of the disease. Arch. Gen. Psychiatry 1989, 46(12):1145-1150.
15. Dickey C.C., McCarley R.W., Voglmaier M.M. An MRI study of superior temporal gyrus volume in women with schizotypal personality disorder. Am. J. Psychiatry 2003, 160:2198-2201.
16. Downhill J.E., Buchsbaum M.S., Hazlett E.A., Barth S., Lees Roitman S., Nunn M., Lekarev O., Wei T., Shihabuddin L., Mitropoulou V., Silverman J., Siever L.J. Temporal lobe volume determined by magnetic resonance imaging in schizotypal personality disorder and schizophrenia. Schizophr. Res. 2001, 48(2-3):187-199.
17. First M., Spitzer R., Gibbon M. Structured Clinical Interview for DSM-IV Axis I Disorders 1996, New York State Psychiatric Institute, New York, NY.
18. Friedman D.P., Aggleton J.P., Saunders R.C. Comparison of hippocampal, amygdala, and perirhinal projections to the nucleus accumbens: combined anterograde and retrograde tracing study in the Macaque brain. J. Comp. Neurol. 2002, 450(4):345-365.
19. Fudge J.L., Haber S.N. Defining the caudal ventral striatum in primates: cellular and histochemical features. J. Neurosci. 2002, 22(23):10078-10082.
20. Goldstein K.E., Hazlett E.A., New A.S., Haznedar M.M., Newmark R.E., Zelmanova Y., Passarelli V., Weinstein S.R., Canfield E.L., Meyerson D.A., Tang C.Y., Buchsbaum M.S., Siever L.J. Smaller superior temporal gyrus volume specificity in schizotypal personality disorder. Schizophr. Res. 2009, 112(1-3):14-23.
21. Gunduz H., Wu H., Ashtari M., Bogerts B., Crandall D., Robinson D.G., Alvir J., Lieberman J., Kane J., Bilder R. Basal ganglia volumes in first-episode schizophrenia and healthy comparison subjects. Biol. Psychiatry 2002, 51(10):801-808.
22. Haber S.N. The primate basal ganglia: parallel and integrative networks. J. Chem. Neuroanat. 2003, 26(4):317-330.
23. Haber S.N., Knutson B. The reward circuit: linking primate anatomy and human imaging. Neuropsychopharmacology 2010, 35(1):4-26.
24. Hazlett E.A., Buchsbaum M.S., Haznedar M.M., Newmark R., Goldstein K.E., Zelmanova Y., Glanton C.F., Torosjan Y., New A.S., Lo J.N., Mitropoulou V., Siever L.J. Cortical gray and white matter volume in unmedicated schizotypal and schizophrenia patients. Schizophr. Res. 2008, 101:111-123.
25. Haznedar M.M., Buchsbaum M.S., Hazlett E.A., Shihabuddin L., New A., Siever L.J. Cingulate gyrus volume and metabolism in the schizophrenia spectrum. Schizophr. Res. 2004, 71(2-3):249-262.
26. Hokama H., Shenton M., Nestor P., Kikinis R., Levitt J., Metcalf D., Wible C., O'Donnell B., Jolesz F., McCarley R. Caudate, putamen and globus pallidus volume in schizophrenia: a quantitative MRI study. Psychiatry Res. Neuroimaging 1995, 61:209-229.
27. Howes O.D., Montgomery A.J., Asselin M.C., Murray R.M., Grasby P.M., McGuire P.K. Molecular imaging studies of the striatal dopaminergic system in psychosis and predictions for the prodromal phase of psychosis. Br. J. Psychiatry Suppl. 2007, 51:s13-s18.
28. Keilhoff G., Grecksch G., Bernstein H.G., Roskoden T., Becker A. Risperidone and haloperidol promote survival of stem cells in the rat hippocampus. Eur. Arch. Psychiatry Clin. Neurosci. 2010, 260(2):151-162.
29. Keshavan M.S., Bagwell W.W., Haas G.L., Sweeney J.A., Schooler N.R., Pettegrew J.W. Changes in caudate volume with neuroleptic treatment. Lancet 1994, 344(8934):1434.
30. Kippin T.E., Kapur S., van der Kooy D. Dopamine specifically inhibits forebrain neural stem cell proliferation, suggesting a novel effect of antipsychotic drugs. J. Neurosci. 2005, 25(24):5815-5823.
31. Koo M.S., Levitt J.J., McCarley R.W., Seidman L.J., Dickey C.C., Niznikiewicz M.A., Voglmaier M.M., Zamani P., Long K.R., Kim S.S., Shenton M.E. Reduction of caudate nucleus volumes in neuroleptic-naive female subjects with schizotypal personality disorder. Biol. Psychiatry 2006, 60(1):40-48.
32. Levitt J.J., McCarley R.W., Dickey C.C., Voglmaier M.M., Niznikiewicz M.A., Seidman L.J., Hirayasu Y., Ciszewski A.A., Kikinis R., Jolesz F.A., Shenton M.E. MRI study of caudate nucleus volume and its cognitive correlates in neuroleptic-naive patients with schizotypal personality disorder. Am. J. Psychiatry 2002, 159(7):1190-1197.
33. Levitt J.J., Westin C.F., Nestor P.G., Estepar R.S., Dickey C.C., Voglmaier M.M., Seidman L.J., Kikinis R., Jolesz F.A., McCarley R.W., Shenton M.E. Shape of caudate nucleus and its cognitive correlates in neuroleptic-naive schizotypal personality disorder. Biol. Psychiatry 2004, 55(2):177-184.
34. Li M., Chen Z., Deng W., He Z., Wang Q., Jiang L., Ma X., Wang Y., Chua S.E., Cheung C., McAlonan G.M., Sham P.C., Collier D.A., Gong Q., Li T. Volume increases in putamen associated with positive symptom reduction in previously drug-naive schizophrenia after 6 weeks antipsychotic treatment. Psychol. Med. 2012, 42(7):1475-1483.
35. McCarley R.W., Wible C.G., Frumin M., Hirayasu Y., Levitt J.J., Fischer I.A., Shenton M.E. MRI anatomy of schizophrenia. Biol. Psychiatry 1999, 45(9):1099-1119.
36. Menon V., Anagnoson R.T., Glover G.H., Pfefferbaum A. Functional magnetic resonance imaging evidence for disrupted basal ganglia function in schizophrenia. Am. J. Psychiatry 2001, 158(4):646-649.
37. Miller A.B., Lenzenweger M.F. Schizotypy, social cognition, and interpersonal sensitivity. Personal. Disord. 2012, 3(4):379-392.
38. Mitelman S.A., Brickman A.M., Shihabuddin L., Newmark R., Chu K.W., Buchsbaum M.S. Correlations between MRI-assessed volumes of the thalamus and cortical Brodmann's areas in schizophrenia. Schizophr. Res. 2005, 75(2-3):265-281.
39. Mitelman S.A., Canfield E.L., Chu K.W., Brickman A.M., Shihabuddin L., Hazlett E.A., Buchsbaum M.S. Poor outcome in chronic schizophrenia is associated with progressive loss of volume of the putamen. Schizophr. Res. 2009, 113(2-3):241-245.
40. Mitropoulou V., Harvey P.D., Maldari L.A., Moriarty P.J., New A.S., Silverman J.M., Siever L.J. Neuropsychological performance in schizotypal personality disorder: evidence regarding diagnostic specificity. Biol. Psychiatry 2002, 52(12):1175-1182.
41. Mitropoulou V., Goodman M., Sevy S., Elman I., New A.S., Iskander E.G., Silverman J.M., Breier A., Siever L.J. Effects of acute metabolic stress on the dopaminergic and pituitary-adrenal axis activity in patients with schizotypal personality disorder. Schizophr. Res. 2004, 70(1):27-31.
42. O'Brien L.M., Ziegler D.A., Deutsch C.K., Kennedy D.N., Goldstein J.M., Seidman L.J., Hodge S., Makris N., Caviness V., Frazier J.A., Herbert M.R. Adjustment for whole brain and cranial size in volumetric brain studies: a review of common adjustment factors and statistical methods. Harv. Rev. Psychiatry 2006, 14(3):141-151.
43. Oertel-Knochel V., Linden D.E. Cerebral asymmetry in schizophrenia. Neuroscientist 2011, 17(5):456-467.
44. Ohnuma T., Kimura M., Takahashi T., Iwamoto N., Arai H. A magnetic resonance imaging study in first-episode disorganized-type patients with schizophrenia. Psychiatry Clin. Neurosci. 1997, 51(1):9-15.
45. Okugawa G., Nobuhara K., Takase K., Saito Y., Yoshimura M., Kinoshita T. Olanzapine increases grey and white matter volumes in the caudate nucleus of patients with schizophrenia. Neuropsychobiology 2007, 55(1):43-46.
46. Parent A., Hazrati L.N. Functional anatomy of the basal ganglia. I. The cortico-basal ganglia-thalamo-cortical loop. Brain Res. 1995, 20(1):91-127.
47. Pfohl B., Blum N., Zimmerman M. Structured Clinical Interview for DSM-IV Personality (SIDP-IV) 1997, American Psychiatric Press, Washington, D.C.
48. Raine A., Lencz T. Conceptual and theoretical issues in schizotypal personality research. Schizotypal Personality 1995, 3-15. Cambridge University Press, New York. A. Raine, T. Lencz, S.A. Mednick (Eds.).
49. Russchen F.T., Bakst I., Amaral D.G., Price J.L. The amygdalostriatal projections in the monkey. An anterograde tracing study. Brain Res. 1985, 329(1-2):241-257.
50. Shihabuddin L., Buchsbaum M., Hazlett E., Haznedar M., Harvey P., Newman A., Schnur D., Spiegel-Cohen J., Wei T., Machac J., Knesaurek K., Vallabhojosula S., Biren M., Ciaravolo T., Luu-Hsia C. Dorsal striatal size, shape, and metabolic rate in neuroleptic-naive and previously medicated schizophrenic patients performing a verbal learning task. Arch. Gen. Psychiatry 1998, 55:235-243.
51. Shihabuddin L., Buchsbaum M., Hazlett E., Silverman J., New A., Brickman A., Mitropoulou V., Nunn M., Fleischman M., Tang C., Siever L. Striatal size and relative glucose metabolic rate in schizotypal personality disorder and schizophrenia. Arch. Gen. Psychiatry 2001, 58(9):877-884.
52. Siever L.J., Davis K.L. The pathophysiology of schizophrenia disorders: perspectives from the spectrum. Am. J. Psychiatry 2004, 161(3):398-413.
53. Siever L.J., Koenigsberg H.W., Harvey P., Mitropoulou V., Laruelle M., Abi-Dargham A., Goodman M., Buchsbaum M. Cognitive and brain function in schizotypal personality disorder. Schizophr. Res. 2002, 54(1-2):157-167.
54. Simpson E.H., Kellendonk C., Kandel E. A possible role for the striatum in the pathogenesis of the cognitive symptoms of schizophrenia. Neuron 2010, 65(5):585-596.
55. Statsoft, Inc. Statistica, 9.0 ed. (Tulsa, OK). http://www.statsoft.com.
56. Talairach J., Tournoux P. Co-planar Stereotaxic Atlas of the Human Brain 1988, Thieme, Stuttgart.
57. Taylor S., Christensen J.D., Holcomb J.M., Garver D.L. Volume increases in striatum associated with positive symptom reduction in schizophrenia: a preliminary observation. Psychiatry Res. 2005, 140(1):85-89.
58. Tritsch N.X., Sabatini B.L. Dopaminergic modulation of synaptic transmission in cortex and striatum. Neuron 2012, 76(1):33-50.